(1R)-N2-1-(3-chloro-4-fluoro-phenyl)-[6-(3-chloro-4-trifluoromethyl-phenyl)-pyrimidin-4-yl]-ethane-1,2-diamine | 1267688-48-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: (1R)-N2-1-(3-chloro-4-fluoro-phenyl)-[6-(3-chloro-4-trifluoromethyl-phenyl)-pyrimidin-4-yl]-ethane-1,2-diamine
• 英文别名: (1R)-1-(3-chloro-4-fluorophenyl)-N'-[6-[3-chloro-4-(trifluoromethyl)phenyl]pyrimidin-4-yl]ethane-1,2-diamine
• CAS: 1267688-48-1
• 化学式: C₁₉H₁₄Cl₂F₄N₄
• 分子量: 445.247
• InChiKey: OGXCORRLCIHDSF-INIZCTEOSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5
• 重原子数：
  29
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.16
• 拓扑面积：
  63.8
• 氢给体数：
  2
• 氢受体数：
  8

文献信息

• [EN] PREPARATION OF PHANTASMIDINE AND ANALOGUES THEREOF<br/>[FR] PRÉPARATION DE PHANTASMIDINE ET DE SES ANALOGUES
  申请人：UNIV BRANDEIS

  公开号：WO2012078608A1

  公开（公告）日：2012-06-14

  Described are methods of synthesizing phantasmidine and analogues thereof from commercially available starting materials. The compounds are useful as pharmacological probes and potential lead compounds for the development of selective nicotinic receptor therapeutics.

  描述了从商业可获得的起始物质中合成幻影啉及其类似物的方法。这些化合物可用作药理学探针，也可作为选择性尼古丁受体治疗药物开发的潜在先导化合物。
• [EN] ETHYLENE DIAMINE MODULATORS OF FATTY ACID AMIDE HYDROLASE<br/>[FR] MODULATEURS D'ÉTHYLÈNE DIAMINE D'UNE AMIDE HYDROLASE D'ACIDE GRAS
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2011022348A1

  公开（公告）日：2011-02-24

  Certain ethylene diamine compounds of Formula (I) are described, which are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, energy metabolism disorders, and movement disorders (e.g., multiple sclerosis). Methods of synthesizing such compounds are also disclosed.

  描述了Formula (I)中的某些乙烯二胺化合物，这些化合物可作为FAAH抑制剂。这种化合物可用于制备药物组合物，并用于治疗由脂肪酸酰胺水解酶(FAAH)活性介导的疾病状态、紊乱和情况，如焦虑、疼痛、炎症、睡眠障碍、进食障碍、能量代谢紊乱和运动障碍(例如多发性硬化)。还公开了合成这种化合物的方法。
• ETHYLENE DIAMINE MODULATORS OF FATTY ACID HYDROLASE
  申请人：Hawryluk Natalie A.

  公开号：US20120149696A1

  公开（公告）日：2012-06-14

  Certain ethylene diamine compounds of Formula (I) are described, which are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, energy metabolism disorders, and movement disorders (e.g., multiple sclerosis). Methods of synthesizing such compounds are also disclosed.

  本文描述了公式（I）的某些乙烯二胺化合物，它们可用作FAAH抑制剂。这些化合物可用于制备药物组合物和治疗由脂肪酸酰胺水解酶（FAAH）活性介导的疾病状态、疾病和情况，如焦虑、疼痛、炎症、睡眠障碍、进食障碍、能量代谢障碍和运动障碍（例如多发性硬化症）的方法。还公开了合成这些化合物的方法。
• US8906914B2
  申请人：——

  公开号：US8906914B2

  公开（公告）日：2014-12-09